Your browser doesn't support javascript.
loading
Variant-specific pathophysiological mechanisms of AFF3 differently influence transcriptome profiles.
Bassani, Sissy; Chrast, Jacqueline; Ambrosini, Giovanna; Voisin, Norine; Schütz, Frédéric; Brusco, Alfredo; Sirchia, Fabio; Turban, Lydia; Schubert, Susanna; Abou Jamra, Rami; Schlump, Jan-Ulrich; DeMille, Desiree; Bayrak-Toydemir, Pinar; Nelson, Gary Rex; Wong, Kristen Nicole; Duncan, Laura; Mosera, Mackenzie; Gilissen, Christian; Vissers, Lisenka E L M; Pfundt, Rolph; Kersseboom, Rogier; Yttervik, Hilde; Hansen, Geir Åsmund Myge; Smeland, Marie Falkenberg; Butler, Kameryn M; Lyons, Michael J; Carvalho, Claudia M B; Zhang, Chaofan; Lupski, James R; Potocki, Lorraine; Flores-Gallegos, Leticia; Morales-Toquero, Rodrigo; Petit, Florence; Yalcin, Binnaz; Tuttle, Annabelle; Elloumi, Houda Zghal; McCormick, Lane; Kukolich, Mary; Klaas, Oliver; Horvath, Judit; Scala, Marcello; Iacomino, Michele; Operto, Francesca; Zara, Federico; Writzl, Karin; Maver, Ales; Haanpää, Maria K; Pohjola, Pia; Arikka, Harri; Kievit, Anneke J A.
Afiliación
  • Bassani S; Center for Integrative Genomics, University of Lausanne, Genopode Building, Lausanne, CH, 1015, Switzerland.
  • Chrast J; Present address: Institute of Medical Genetics, University of Zurich, Zurich, Switzerland.
  • Ambrosini G; Center for Integrative Genomics, University of Lausanne, Genopode Building, Lausanne, CH, 1015, Switzerland.
  • Voisin N; Bioinformatics Competence Center, University of Lausanne, Lausanne, Switzerland.
  • Schütz F; Bioinformatics Competence Center, Ecole Polytechnique Fédérale de Lausanne, Lausanne, Switzerland.
  • Brusco A; Center for Integrative Genomics, University of Lausanne, Genopode Building, Lausanne, CH, 1015, Switzerland.
  • Sirchia F; Present address: Sophia Genetics, St Sulpice, Switzerland.
  • Turban L; Biostatistics Platform, University of Lausanne, Lausanne, Switzerland.
  • Schubert S; Department of Neurosciences Rita Levi-Montalcini, University of Turin, 10126, Turin, Italy.
  • Abou Jamra R; Medical Genetics Unit, Città Della Salute E Della Scienza University Hospital, 10126, Turin, Italy.
  • Schlump JU; Department of Neurosciences Rita Levi-Montalcini, University of Turin, 10126, Turin, Italy.
  • DeMille D; Medical Genetics Unit, Città Della Salute E Della Scienza University Hospital, 10126, Turin, Italy.
  • Bayrak-Toydemir P; Present address: Department of Molecular Medicine, University of Pavia, Pavia, Italy.
  • Nelson GR; Present address: Medical Genetics Unit, IRCCS San Matteo Foundation, Pavia, Italy.
  • Wong KN; Institute of Human Genetics, University of Leipzig Medical Center, Leipzig, Germany.
  • Duncan L; Institute of Human Genetics, University of Leipzig Medical Center, Leipzig, Germany.
  • Mosera M; Institute of Human Genetics, University of Leipzig Medical Center, Leipzig, Germany.
  • Gilissen C; Department of Pediatrics, Centre for Neuromedicine, Gemeinschaftskrankenhaus Herdecke Gerhard-Kienle-Weg, Herdecke, Germany.
  • Vissers LELM; Genomics Analysis 396, ARUP Laboratories, Salt Lake City, UT, USA.
  • Pfundt R; Pediatric Neurology, University of Utah School of Medicine, Salt Lake City, UT, USA.
  • Kersseboom R; Pediatric Neurology, University of Utah School of Medicine, Salt Lake City, UT, USA.
  • Yttervik H; Pediatric Neurology, University of Utah School of Medicine, Salt Lake City, UT, USA.
  • Hansen GÅM; Department of Pediatrics, Medical Center North, Vanderbilt University Medical Center, Nashville, TN, USA.
  • Smeland MF; Present address: Mayo Clinic, Rochester, MN, USA.
  • Butler KM; Department of Pediatrics, Medical Center North, Vanderbilt University Medical Center, Nashville, TN, USA.
  • Lyons MJ; Department of Human Genetics, Research Institute for Medical Innovation, Radboud University Medical Center, Nijmegen, The Netherlands.
  • Carvalho CMB; Department of Human Genetics, Research Institute for Medical Innovation, Radboud University Medical Center, Nijmegen, The Netherlands.
  • Zhang C; Department of Human Genetics, Research Institute for Medical Innovation, Radboud University Medical Center, Nijmegen, The Netherlands.
  • Lupski JR; Center for Genetic Developmental Disorders Southwest, Zuidwester, Middelharnis, The Netherlands.
  • Potocki L; Department of Medical Genetics, University Hospital of North Norway, Tromsø, Norway.
  • Flores-Gallegos L; Department of Medical Genetics, University Hospital of North Norway, Tromsø, Norway.
  • Morales-Toquero R; Department of Pediatric Rehabilitation, University Hospital of North Norway, Tromsø, Norway.
  • Petit F; Greenwood Genetic Center, Greenwood, SC, USA.
  • Yalcin B; Greenwood Genetic Center, Greenwood, SC, USA.
  • Tuttle A; Pacific Northwest Research Institute (PNRI), Broadway, Seattle, WA, USA.
  • Elloumi HZ; Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX, USA.
  • McCormick L; Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX, USA.
  • Kukolich M; Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX, USA.
  • Klaas O; Human Genome Sequencing Center, Baylor College of Medicine, Houston, TX, USA.
  • Horvath J; Department of Pediatrics, Baylor College of Medicine, Houston, TX, USA.
  • Scala M; Texas Children's Hospital, Houston, TX, USA.
  • Iacomino M; Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX, USA.
  • Operto F; Texas Children's Hospital, Houston, TX, USA.
  • Zara F; Hospital Ángeles Puebla, Puebla, Mexico.
  • Writzl K; Hospital Ángeles Puebla, Puebla, Mexico.
  • Maver A; CHU Lille, Clinique de Génétique, 59000, Lille, France.
  • Haanpää MK; Inserm UMR1231, University of Burgundy, 21000, Dijon, France.
  • Pohjola P; GeneDx, Gaithersburg, MD, USA.
  • Arikka H; GeneDx, Gaithersburg, MD, USA.
  • Kievit AJA; Department of Genetics, Cook Children's Medical Center, Cook Children's Health Care System, Fort Worth, TX, USA.
Genome Med ; 16(1): 72, 2024 05 30.
Article en En | MEDLINE | ID: mdl-38811945
ABSTRACT

BACKGROUND:

We previously described the KINSSHIP syndrome, an autosomal dominant disorder associated with intellectual disability (ID), mesomelic dysplasia and horseshoe kidney, caused by de novo variants in the degron of AFF3. Mouse knock-ins and overexpression in zebrafish provided evidence for a dominant-negative mode of action, wherein an increased level of AFF3 resulted in pathological effects.

METHODS:

Evolutionary constraints suggest that other modes-of-inheritance could be at play. We challenged this hypothesis by screening ID cohorts for individuals with predicted-to-be damaging variants in AFF3. We used both animal and cellular models to assess the deleteriousness of the identified variants.

RESULTS:

We identified an individual with a KINSSHIP-like phenotype carrying a de novo partial duplication of AFF3 further strengthening the hypothesis that an increased level of AFF3 is pathological. We also detected seventeen individuals displaying a milder syndrome with either heterozygous Loss-of-Function (LoF) or biallelic missense variants in AFF3. Consistent with semi-dominance, we discovered three patients with homozygous LoF and one compound heterozygote for a LoF and a missense variant, who presented more severe phenotypes than their heterozygous parents. Matching zebrafish knockdowns exhibit neurological defects that could be rescued by expressing human AFF3 mRNA, confirming their association with the ablation of aff3. Conversely, some of the human AFF3 mRNAs carrying missense variants identified in affected individuals did not rescue these phenotypes. Overexpression of mutated AFF3 mRNAs in zebrafish embryos produced a significant increase of abnormal larvae compared to wild-type overexpression further demonstrating deleteriousness. To further assess the effect of AFF3 variation, we profiled the transcriptome of fibroblasts from affected individuals and engineered isogenic cells harboring + / + , KINSSHIP/KINSSHIP, LoF/ + , LoF/LoF or KINSSHIP/LoF AFF3 genotypes. The expression of more than a third of the AFF3 bound loci is modified in either the KINSSHIP/KINSSHIP or the LoF/LoF lines. While the same pathways are affected, only about one third of the differentially expressed genes are common to the homozygote datasets, indicating that AFF3 LoF and KINSSHIP variants largely modulate transcriptomes differently, e.g. the DNA repair pathway displayed opposite modulation.

CONCLUSIONS:

Our results and the high pleiotropy shown by variation at this locus suggest that minute changes in AFF3 function are deleterious.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Pez Cebra / Transcriptoma / Discapacidad Intelectual Límite: Animals / Female / Humans / Male Idioma: En Revista: Genome Med Año: 2024 Tipo del documento: Article País de afiliación: Suiza Pais de publicación: Reino Unido

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Pez Cebra / Transcriptoma / Discapacidad Intelectual Límite: Animals / Female / Humans / Male Idioma: En Revista: Genome Med Año: 2024 Tipo del documento: Article País de afiliación: Suiza Pais de publicación: Reino Unido